Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy

April 2017 in “ Clinical Drug Investigation ”

Francesco Lapi, Monica Simonetti, Iacopo Cricelli, Claudio Cricelli, Nicoletta Cassano, Gino Antonio Vena

cyproterone acetate ethinylestradiol CPA/EE hormonal contraceptives acne hyperandrogenic conditions European Medicines Agency EMA CPA EE

TLDR The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

The study analyzed the prescription patterns of Cyproterone Acetate/Ethinylestradiol (CPA/EE) in Italy, using data from 1,189 new users (495 in 2011, 446 in 2012, and 261 in 2014) to determine if prescribing practices changed following the European Medicines Agency's (EMA) 2013 recommendation on CPA/EE's risk profile. The findings showed that the concomitant use of CPA/EE with other hormonal contraceptives was low (1% in 2011-2012 and 2% in 2014) and that the proportion of patients with acne or other hyperandrogenic conditions remained consistent before and after the EMA recommendation. Despite a decrease in CPA/EE prescriptions, there was no significant change in the prescription appropriateness for hyperandrogenic conditions or in the concomitant use of other hormonal contraceptives. The study highlighted the importance of following prescribing guidelines to ensure the safe use of CPA/EE.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

Prescribing of Cyproterone Acetate/Ethinylestradiol in UK General Practice: A Retrospective Descriptive Study Using The Health Improvement Network

research Prescribing of Cyproterone Acetate/Ethinylestradiol in UK General Practice: A Retrospective Descriptive Study Using The Health Improvement Network

6 citations, October 2016 in “Contraception”

The medication cyproterone acetate/ethinylestradiol is usually prescribed correctly for acne after other treatments don't work.

Related Community Posts Join

6 / 81 results

community 14 Months on nuclear stack (0,5 DUT and 15mg oral Minox and no regrowth. Aga is impossible to beat

in Progress Pictures 11 months ago

The user has been on a hair loss treatment for 14 months using dutasteride and oral minoxidil without seeing regrowth and is considering adding more drugs due to the psychological impact of hair loss. However, replies suggest the user may not actually be experiencing noticeable hair loss.

community Cyproterone Acetate. Hair has stopped falling out ever since starting it. Is this a good sign?

in Transgender 6 upvotes 3 years ago

Cyproterone Acetate stopped hair loss and led to regrowth on the temples for a transgender individual, which is considered a good sign. Unlike Minoxidil and Finasteride, which can cause initial shedding, Cyproterone did not cause shedding.

community Anyone who used topical bicalutamide/estradiol/cyproterone acetate /spironolacton? (Need advice)

in Treatment 5 upvotes 4 months ago

A user is seeking advice on the efficacy and side effects of homemade topical solutions for hair loss, specifically bicalutamide, estradiol, cyproterone acetate, and spironolactone, as they cannot access RU58841 or pyrilutamide.

community Treating male pattern baldness in a transgender woman using cyproterone acetate, finasteride and biotin.

in Finasteride 6 upvotes 8 years ago

The conversation discusses treating male pattern baldness in a transgender woman using cyproterone acetate, finasteride, and biotin. The original poster shared their experience for others who might be in a similar situation.

community Unorthodox recovery timeline - 2.5 years minoxidil, 0.5 years finasteride, 2 years HRT

in Progress Pictures 6 upvotes 1 year ago

The post discusses a user's successful hair recovery using minoxidil, finasteride, and hormone replacement therapy (HRT) with cyproterone acetate and estradiol. The user experienced significant improvement in hair density and hairline recovery.

community Extreme regimen and still miniaturized hairs. AGA is just impossible to beat.

in Insane 35 upvotes 1 year ago

A user's extreme regimen for hair loss, which includes taking oral and topical medications such as minoxidil, dutasteride, cyproterone acetate and bicalutamide, but still experiencing miniaturization. Suggestions were made to try other treatments such as RU58841 and Pyrilutamide, while also considering mental health treatment and advice on lookmaxxing.

Related Research

1 / 1 results

research Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy

3 citations, April 2017 in “Clinical Drug Investigation”

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.